Bioengineers have developed a new construction kit for building custom sense-and-respond circuits in human cells. The research could revolutionize therapies for complex conditions like autoimmune ...
Huch’s pancreatic organoids are now a promising avenue for disease modeling and generating precision medicines to treat ...
Much of our knowledge of the protein PD-1, a leading cancer treatment target, comes from studies in mice. In a comprehensive assessment of PD-1, researchers have found that PD-1 in mice is ...
Quantum technology company Alice & Bob outlines its plan for quantum computing by 2030, but how feasible is that goal?
Scientists mapped how aging alters gene expression across brain cell types in mice, revealing immune activation, neuronal ...
Study findings spotlight a highly potent source of Ebola virus shedding with the potential for person-to-person transmission.
Sadiq Khan, Gareth Southgate and hundreds more have been recognised in the 2025 New Year Honours list. Special honours are given to people who make outstanding contributions to their community and the ...
Following the open science principle of accessibility, “A Universe of Sound” helps members of the public who are blind or low vision experience NASA data in a new sensory way. Sighted users also enjoy ...
It's a really complicated, chaotic system," Brown told Live Science. "Typically, about five years is when the accuracy of the model starts to get to the point where it's not as good as we would ...
From periods of rapid aging in our 40s and 60s to ancient brains that don’t decompose, here are some of the year’s most intriguing stories about human biology It can sometimes feel like health ...
A small, more affordable Model Y is coming to the U.S. in 2025, says an automobile intelligence firm. This comes after a series of statements by Tesla executives about “affordable” models ...
Call it a reasoning renaissance. In the wake of the release of OpenAI’s o1, a so-called reasoning model, there’s been an explosion of reasoning models from rival AI labs. In early November ...